
David Homewood
Articles
-
Oct 4, 2023 |
bjui-journals.onlinelibrary.wiley.com | David Homewood |Jonathan O'Brien |Todd Manning |Brian Kelly
CA chylous ascites RPLND retroperitoneal lymph node dissection Introduction Retroperitoneal lymph node dissection (RPLND) is an important part of multimodal therapy for node-positive germ cell malignancy [1-4]. However, due to wide heterogeneity in patient status, disease biology and tumour locations, RPLND can be challenging and risky [1]. One such risk is iatrogenic chylous ascites (CA; 8% of cases) [1].
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →